Adv Sci (Weinh). 2025 Sep 23:e03289. doi: 10.1002/advs.202503289. Online ahead of print. ABSTRACT Single-cell technologies have transformed the understanding of […]
Endocr Connect. 2025 Sep 23:EC-25-0368. doi: 10.1530/EC-25-0368. Online ahead of print. ABSTRACT The 2022 recommendations of the European Calcified Tissue
Int J Rheum Dis. 2025 Sep;28(9):e70418. doi: 10.1111/1756-185x.70418. ABSTRACT OBJECTIVE: Acute gout flares (AGF) are a significant burden to healthcare
Adv Sci (Weinh). 2025 Sep 23:e13170. doi: 10.1002/advs.202413170. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) is a autoimmune disease
J Intern Med. 2025 Sep 23. doi: 10.1111/joim.70023. Online ahead of print. ABSTRACT BACKGROUND: VEXAS syndrome is an autoinflammatory disease
Hematology. 2025 Dec;30(1):2551454. doi: 10.1080/16078454.2025.2551454. Epub 2025 Sep 23. ABSTRACT OBJECTIVE: Primary immune thrombocytopenia (ITP) is a heterogeneous disease. antinuclear
Cureus. 2025 Aug 20;17(8):e90600. doi: 10.7759/cureus.90600. eCollection 2025 Aug. ABSTRACT Introduction Systemic lupus erythematosus (SLE), systemic sclerosis, and dermatomyositis are
Cureus. 2025 Aug 22;17(8):e90750. doi: 10.7759/cureus.90750. eCollection 2025 Aug. ABSTRACT Systemic lupus erythematosus (SLE) is an autoimmune disease that impacts
Cureus. 2025 Aug 21;17(8):e90706. doi: 10.7759/cureus.90706. eCollection 2025 Aug. ABSTRACT Olanzapine, a second-generation antipsychotic, is generally well tolerated but can
Cureus. 2025 Aug 21;17(8):e90681. doi: 10.7759/cureus.90681. eCollection 2025 Aug. ABSTRACT Hydroxychloroquine (HCQ) is an anti-malarial drug safely used in rheumatologic
J Clin Rheumatol. 2025 Sep 23. doi: 10.1097/RHU.0000000000002283. Online ahead of print. ABSTRACT BACKGROUND/OBJECTIVE: Pegloticase is indicated to lower serum
Clin Teach. 2025 Dec;22(6):e70216. doi: 10.1111/tct.70216. NO ABSTRACT PMID:40984750 | DOI:10.1111/tct.70216
Hum Brain Mapp. 2025 Oct 1;46(14):e70299. doi: 10.1002/hbm.70299. ABSTRACT Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, with cognitive
a rheumatologist. Patients with uncontrolled gout could bene t. from additional/alternative approaches such. as the adoption of a treat-to-target …
J Intern Med. 2025 Sep 22. doi: 10.1111/joim.70024. Online ahead of print. ABSTRACT BACKGROUND: The optimal remission induction therapy for
Med Phys. 2025 Oct;52(10):e70010. doi: 10.1002/mp.70010. ABSTRACT BACKGROUND: Quantitative assessment of inflammation from hand and forefoot MRI scans is crucial
BMC Rheumatol. 2025 Sep 22;9(1):105. doi: 10.1186/s41927-025-00566-z. NO ABSTRACT PMID:40983977 | DOI:10.1186/s41927-025-00566-z
ESC Heart Fail. 2025 Sep 22. doi: 10.1002/ehf2.15424. Online ahead of print. ABSTRACT PURPOSE: Finerenone, a highly selective non-steroidal mineralocorticoid
Ophthalmol Ther. 2025 Sep 23. doi: 10.1007/s40123-025-01237-5. Online ahead of print. ABSTRACT INTRODUCTION: This study aims to describe complications of
Clin Rheumatol. 2025 Sep 22. doi: 10.1007/s10067-025-07697-1. Online ahead of print. ABSTRACT INTRODUCTION/OBJECTIVES: Seasonal variation may influence musculoskeletal pain, and
Mol Syst Biol. 2025 Sep 22. doi: 10.1038/s44320-025-00149-7. Online ahead of print. ABSTRACT Immune-mediated inflammatory diseases remain plagued by poor
Nat Commun. 2025 Sep 22;16(1):8299. doi: 10.1038/s41467-025-63935-9. ABSTRACT Sjögren’s disease (SjD) is an autoimmune disease that causes salivary gland dysfunction
Sci Rep. 2025 Sep 22;15(1):32625. doi: 10.1038/s41598-025-19773-2. NO ABSTRACT PMID:40983607 | DOI:10.1038/s41598-025-19773-2
BMJ Open. 2025 Sep 22;15(9):e104813. doi: 10.1136/bmjopen-2025-104813. ABSTRACT OBJECTIVE: To assess the feasibility of conducting a definitive randomised controlled trial
BMJ Open. 2025 Sep 22;15(9):e092849. doi: 10.1136/bmjopen-2024-092849. ABSTRACT OBJECTIVES: This study aimed to investigate the associations between body mass index
RMD Open. 2025 Sep 21;11(3):e006024. doi: 10.1136/rmdopen-2025-006024. ABSTRACT BACKGROUND: Diffuse idiopathic skeletal hyperostosis (DISH) is considered a slowly progressive condition,
RMD Open. 2025 Sep 21;11(3):e005899. doi: 10.1136/rmdopen-2025-005899. ABSTRACT INTRODUCTION: Patients with arthralgia at-risk for rheumatoid arthritis (RA) experience considerable functional
